Literature DB >> 3891049

A review of changes in vascular smooth muscle functions in hypertension: isolated tissue versus in vivo studies.

C R Triggle, I Laher.   

Abstract

The role of altered vascular smooth muscle function in the etiology of essential hypertension has been extensively studied by a number of investigators. The results obtained from in vivo studies do not always correlate with results from in vitro studies and it is not always apparent whether the results reflect differences related to hypertension or to the genetic background of the animal model. In vitro and perfused vascular bed studies in our laboratory have utilized the spontaneously hypertensive rat (SHR), the normotensive Wistar Kyoto rat (WKY), genetically related crossbred rats (F1, F2, and BC1), and also Dahl salt-sensitive (DS) and salt-resistant (DR) rats. The role of altered smooth muscle function in relation to the development of the elevated blood pressure (BP) of the SHR or DS rat was studied and emphasis was placed on determining the role of altered neuronal uptake1 (U1) in hypertensives in masking elevated postsynaptic sensitivity to noradrenaline. In addition, the relationship between postsynaptic sensitivity to cations and BP was assessed. Such studies have indicated that alterations in postsynaptic sensitivity, U1 activity, and sensitivity to cations are not entirely consistent with the etiology of hypertension in the SHR and DS rat but may simply reflect genetic strain differences between the hypertensive and normotensive animals.

Entities:  

Mesh:

Year:  1985        PMID: 3891049     DOI: 10.1139/y85-065

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  4 in total

1.  Reactivity and sensitivity of mesenteric vascular beds and aortic rings of spontaneously hypertensive rats to endothelin: effects of calcium entry blockers.

Authors:  L Criscione; P Nellis; B Riniker; H Thomann; R Burdet
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

2.  Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy.

Authors:  J R Martens; P Y Reaves; D Lu; M J Katovich; K H Berecek; S P Bishop; M K Raizada; C H Gelband
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Effect of treatment with cholecalciferol on the membrane potential and contractility of aortae from spontaneously hypertensive rats.

Authors:  E G Silva; L M Vianna; P Okuyama; T B Paiva
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

4.  Augmented agonist-induced Ca(2+)-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells.

Authors:  S Satoh; R Kreutz; C Wilm; D Ganten; G Pfitzer
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.